Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...
While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the ...
The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...
FDA employees are reportedly eyeing exits amid talks of Robert F. Kennedy Jr. joining Trump's administration. Concerns extend ...
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Robert F. Kennedy Jr.’s selection Thursday as President-elect Donald Trump’s Health and Human Services secretary nominee sent shockwaves through Washington.